Status:
UNKNOWN
COVID-19 Prevalence in HIV-infected Patients
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Brief Summary
North-east area of France was hit in February 2020 by the new coronavirus disease, more severely than other French regions. Factors affecting the evolution of the disease and its severity have been qu...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- adults (\> 18 years)
- HIV-infected patients
- subjects with social insurance
- subjects able to understand study purposes, and to give a written and informed consent
- Exclusion Criteria :
- subjects unable to understand informations on the study, and to provide informed consent
- subjects under guardianship or curatorship
- subjects under judicial protection
Exclusion
Key Trial Info
Start Date :
November 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 3 2022
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04515225
Start Date
November 4 2020
End Date
May 3 2022
Last Update
August 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpitaux Universitaires de Strasbourg
Strasbourg, France, 67091